ACPU
EW icon

Arrowgrass Capital Partners (US)’s Edwards Lifesciences EW Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-150,000
Closed -$3.55M – 419
2015
Q3 		$3.55M Buy
+150,000
New +$3.62M 0.07% 190

Other funds holding EW

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s EW Position: Q4 2015 in Review

Arrowgrass Capital Partners (US) sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 150,000 shares — an estimated $3.55M sold.

Arrowgrass Capital Partners (US) first reported a position in EW in Q3 2015 and held it in 1 quarter. The position peaked at $3.55M in Q3 2015. 604 funds tracked by Wall St. Rank hold EW as of Q4 2015.

  • Arrowgrass Capital Partners (US) reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 150,000 Edwards Lifesciences shares in Q4 2015, an estimated $3.55M.
  • Arrowgrass Capital Partners (US) first reported a position in Edwards Lifesciences in Q3 2015 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Edwards Lifesciences position peaked at $3.55M in Q3 2015.
  • 604 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2015, filed 16 Feb 2016.